Cancer Cell

• 

  Publication Venue For

  • Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis..  36:319-336.e7. 2019
  • Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets..  35:588-602.e10. 2019
  • Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases.  35:267-282.e7. 2019
  • Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway..  34:893-905.e8. 2018
  • A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers..  33:690-705.e9. 2018
  • Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas..  33:721-735.e8. 2018
  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy..  33:676-689.e3. 2018
  • lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer..  33:706-720.e9. 2018
  • Genomic and Epigenomic Profiling of High-Risk Intestinal Metaplasia Reveals Molecular Determinants of Progression to Gastric Cancer..  33:137-150.e5. 2018
  • Enhancing CD8+ T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy.  32:377-391.e9. 2017
  • Erythropoietin Stimulates Tumor Growth via EphB4..  28:610-622. 2015
  • Par-4 downregulation promotes breast cancer recurrence by preventing multinucleation following targeted therapy..  24:30-44. 2013
  • LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin..  23:143-158. 2013
  • Cell Autonomous Role of PTEN in Regulating Castration-Resistant Prostate Cancer Growth.  19:792-804. 2011
  • Identification of CD15 as a Marker for Tumor-Propagating Cells in a Mouse Model of Medulloblastoma (DOI:10.1016/j.ccr.2008.12.016).  16:267. 2009
  • AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer..  16:21-32. 2009
  • Increased radioresistance and accelerated B cell lymphomas in mice with Mdmx mutations that prevent modifications by DNA-damage-activated kinases..  16:33-43. 2009
  • Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo..  12:528-541. 2007
  • Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas..  12:215-229. 2007
  • Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma..  12:115-130. 2007
  • RXR is an essential component of the oncogenic PML/RARA complex in vivo..  12:23-35. 2007
  • Targeted expression of BikDD eradicates pancreatic tumors in noninvasive imaging models..  12:52-65. 2007
  • Tribbles homolog 2 inactivates C/EBPalpha and causes acute myelogenous leukemia..  10:401-411. 2006
  • mILC-ing the mouse mammary gland: A model for invasive lobular carcinoma..  10:347-349. 2006
  • Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance..  8:381-392. 2005
  • Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity..  8:99-110. 2005
  • Activation of RalA is critical for Ras-induced tumorigenesis of human cells..  7:533-545. 2005
  • Protein farnesyltransferase in embryogenesis, adult homeostasis, and tumor development..  7:313-324. 2005
  • The convergence of cancer prevention and therapy in early-phase clinical drug development..  6:321-326. 2004
  • Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules..  5:429-441. 2004
  • Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway..  5:329-339. 2004
  • Developmental biology informs cancer: the emerging role of the hedgehog signaling pathway in upper gastrointestinal cancers..  4:245-247. 2003
  • Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene..  3:297-302. 2003
  • ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation..  1:145-155. 2002
  • Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia. 2018